Pharma
Once Fitbit has cleared its own atrial fibrillation detection feature, it will be working with the pharmas to develop content that will help at-risk users discuss their heart health with a provider.
Medisafe and its partner's joint program enrolled "thousands" of cardiometabolic patients and posted adherence increases greater those of the Medisafe app alone.
This is the company's second platform-focused expansion within the last year.
These three tools that find the middle ground between breakthrough technology and user-friendly interfaces.
From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.
The companies will be using DEARhealth's platform, which integrates AI into EHRs to predict health outcomes.
There's continued resistance from many pharmaceutical industry executives, who think it's never possible to safely store sensitive data in the cloud.
For all the potential benefits of SaaS-based analytics and AI apps, privacy concerns remain, slowing data sharing and suggesting the need for new approaches to cloud security.
Pharma companies also continued to explore the promises of digital therapeutics.
In July, MobiHealthNews will focus on how pharma companies are using digital tools for R&D, real-world evidence collection and exploring new therapeutics.